Initiator Pharma A/S (ST:INIT) — Stock Price

Skr2.60 SEK
▲ 0.39% today

Initiator Pharma A/S (ST:INIT) is currently trading at Skr2.60 SEK, up 0.39% today. Over the past 52 weeks, shares have ranged between Skr2.24 and Skr3.95. This page tracks Initiator Pharma A/S's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Initiator Pharma A/S worth.

Initiator Pharma A/S (INIT) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Initiator Pharma A/S's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Initiator Pharma A/S Income Statement — Revenue, Profit & Earnings by Year

Initiator Pharma A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr0.00 Skr0.00 Skr0.00 Skr0.00 Skr0.00
Cost of Revenue Skr11.07K Skr23.41K Skr38.42K Skr21.63K Skr9.30K
Gross Profit Skr-11.07K Skr-23.41K Skr-38.42 Million Skr-21.63K Skr-9.30K
Research & Development Skr1.78K Skr15.30K Skr26.34K Skr11.81K Skr5.19K
SG&A Skr3.43 Million Skr3.62 Million Skr3.31 Million Skr1.44 Million
Total Operating Expenses Skr3.43K Skr3.62K Skr3.31 Million Skr1.45K Skr1.23K
Operating Income Skr-14.50K Skr-27.03K Skr-41.74 Million Skr-23.07K Skr-10.53K
EBITDA Skr-14.50K Skr-27.03K Skr-41.74 Million Skr-23.06K Skr-10.51K
EBIT Skr-14.50K Skr-27.03K Skr-41.74 Million Skr-23.07K Skr-10.53K
Interest Expense Skr2.00K Skr3.71 Million Skr2.39 Million Skr1.17 Million Skr291.00K
Income Before Tax Skr-14.84K Skr-27.71K Skr-44.13 Million Skr-24.24K Skr-10.24K
Income Tax Expense Skr-1.90K Skr-4.83K Skr-5.68 Million Skr-3.18K Skr-1.54K
Net Income Skr-12.93K Skr-22.87K Skr-38.45 Million Skr-21.06 Million Skr-8.70 Million

Initiator Pharma A/S Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Initiator Pharma A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr15.29 Million Skr29.79 Million Skr48.34 Million Skr53.70 Million Skr15.60 Million
Total Current Assets Skr15.28 Million Skr29.77 Million Skr48.33 Million Skr53.70 Million Skr15.59 Million
Cash & Equivalents
Short-term Investments Skr200.00K
Net Receivables Skr599.00K Skr1.71 Million Skr945.00K Skr545.00K
Inventory
Property, Plant & Equipment
Goodwill
Total Liabilities Skr510.00K Skr18.62 Million Skr14.32 Million Skr18.71 Million Skr1.19 Million
Total Current Liabilities Skr510.00K Skr3.19 Million Skr1.75 Million Skr5.42 Million Skr1.19 Million
Long-term Debt Skr0.00 Skr15.44 Million Skr12.58 Million Skr13.29 Million Skr0.00
Net Debt Skr-13.37 Million Skr-8.70 Million Skr-26.34 Million Skr-20.86 Million Skr-13.50 Million
Total Stockholder Equity Skr14.78 Million Skr11.16 Million Skr34.02 Million Skr34.99 Million Skr14.41 Million
Retained Earnings Skr8.88 Million Skr5.65 Million Skr28.52 Million Skr30.40 Million Skr11.50 Million

Initiator Pharma A/S Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Initiator Pharma A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr-12.08 Million Skr-17.65 Million Skr-32.70 Million Skr-34.10 Million Skr-8.06 Million
Capital Expenditures Skr0.00 Skr0.00 Skr0.00 Skr0.00 Skr0.00
Free Cash Flow Skr-12.08 Million Skr-17.65 Million Skr-32.70 Million Skr-34.10 Million Skr-8.06 Million
Investing Cash Flow Skr-17.00K Skr-17.00K Skr-17.00K
Financing Cash Flow Skr1.11 Million Skr2.87 Million Skr37.48 Million Skr54.94 Million Skr14.01 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr0.00 Skr11.00K Skr26.00K
Change in Cash Skr-10.96 Million Skr-14.78 Million Skr4.77 Million Skr20.84 Million Skr5.94 Million

Initiator Pharma A/S Earnings History — EPS Actual vs. Analyst Estimates

Track Initiator Pharma A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 20, 2026
Nov 21, 2025 -0.09
Aug 22, 2025 -0.10
May 09, 2025 -0.07
Feb 28, 2025 -0.02
Nov 29, 2024 -0.09
Aug 23, 2024 -0.13
May 10, 2024 -0.12